Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Stephen Oxley purchased 27 shares of the business’s stock in a transaction on Wednesday, February 19th. The shares were acquired at an average price of GBX 1,451 ($18.39) per share, for a total transaction of £391.77 ($496.41).
Stephen Oxley also recently made the following trade(s):
- On Wednesday, November 27th, Stephen Oxley purchased 7,407 shares of Johnson Matthey stock. The shares were purchased at an average cost of GBX 1,343 ($17.02) per share, for a total transaction of £99,476.01 ($126,046.64).
Johnson Matthey Stock Up 0.3 %
Shares of LON:JMAT opened at GBX 1,449.05 ($18.36) on Friday. The stock has a market capitalization of £2.42 billion, a P/E ratio of 24.62, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. Johnson Matthey PLC has a 12-month low of GBX 1,295.54 ($16.42) and a 12-month high of GBX 1,917.07 ($24.29). The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 62.73. The stock’s 50-day moving average price is GBX 1,382.14 and its 200-day moving average price is GBX 1,481.39.
Johnson Matthey Cuts Dividend
The business also recently announced a dividend, which was paid on Tuesday, February 4th. Shareholders of record on Thursday, December 5th were given a GBX 22 ($0.28) dividend. This represents a yield of 1.47%. The ex-dividend date was Thursday, December 5th. Johnson Matthey’s dividend payout ratio (DPR) is presently 130.84%.
Analyst Upgrades and Downgrades
JMAT has been the subject of a number of analyst reports. Jefferies Financial Group reiterated a “buy” rating and set a GBX 1,800 ($22.81) price objective on shares of Johnson Matthey in a report on Tuesday, December 17th. Berenberg Bank dropped their price objective on Johnson Matthey from GBX 1,650 ($20.91) to GBX 1,500 ($19.01) and set a “hold” rating on the stock in a research note on Thursday, November 28th.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also
- Five stocks we like better than Johnson Matthey
- What Are Dividend Achievers? An Introduction
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Insider Trades May Not Tell You What You Think
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Where to Find Earnings Call Transcripts
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.